Sunday, August 28, 2016 3:53:06 PM
Now here is a partial argument and we must go back to the vote to INCREASE the authorized shares last year and here is why. Was there any partnership talks/emails in exchange between the company and others (Big Pharmas or research institutions..etc..etc ??) and if so, shareholders are due to all access of these negotiations because it is highly likely that "Authorized Shares" would be part of the deal to give that Big Pharma party or research institution a certain percent ownership in Peregrine Pharmaceuticals... correct ?
Further, if part of the strategy of negotiations of that Big Pharma was to INCREASE ownership in Peregrine Pharmaceuticals, then now we fast forward a year later to this current time "AFTER" some negotiations take place that a Reverse Split is brought, it would very likely be due to support a negotiation deal where the other party was seeking a bigger ownership in Peregrine Pharmaceuticals.
Can Peregrine request a RS based on the price under a $1 ?? Certainly yes and that would be their argument, legally.
Could a stock be manipulated downward, under a $1 in order to force Peregrine into a situation like this that covers them for the reasons why they would request such a RS ? Certainly yes
Could ALL shareholders reading this realize what is going on and ALL send in registered letters to Peregrine/SEC/Nasdaq and bring up all circumstances on going and request to see the records of when negotiations began and certain stock trading activities, along with stock ownership from Broadridge Corporate Issuer Solutions ?? Certainly yes and when all the facts surface, things may change big time.
Remember, the "COMPONENTS" that comprise the common stock capital account include ==>> authorized shares !!, WHEN we are talking negotiations with any other Big Pharma and these are the reasons why authorized shares are important, in deal making and Big Pharma will stock at nothing to control PS Targeting rights... including sabotage and holding a stock under a buck to possibly force a RS and all the while, knowing.... authorized shares are their for the taking (of control of PS Targeting) and ultimately force some retail to accept a much cheaper buyout than originally planned.
Shareholders better start to understand how Big Pharma works and all better start sending in and making their voices heard--- that we want ALL shares, including prior-negotiation talks of possible AUTHORIZED shares to be reduced... just like all common shares would be reduced.
Again, this is all IF IF IF Peregrine goes this route and shareholders should all take precautionary steps now, vs later when its too late.
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:33:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:32:11 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM